Recent News

• 01.27.2025 - Phase 1 AK006 Trial Results
• 01.27.2025 - Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring

Recent Filings

• 02.03.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 01.27.2025 - 8-K Current report
• 01.27.2025 - EX-99.1 EX-99.1
• 01.13.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 12.09.2024 - 4 Statement of changes in beneficial ownership of securities
• 12.06.2024 - 144 Report of proposed sale of securities